Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

What's new

New heart disease drug to be made available to NHS patients through ground-breaking collaboration

Up to 30,000 lives could be saved over the next decade thanks to a proposed pioneering government collaboration with pharmaceutical company Novartis to tackle heart disease – a leading cause of death in the UK.

BHF Associate Medical Director awarded MBE in New Year Honours list

Professor Jeremy Pearson, the BHF’s longest serving Associate Medical Director, has been awarded an MBE in the Queen’s New Year Honours list for services to medical research.

New target identified to help prevent dangerous heart rhythms after heart attack

For many years, we have been using beta-blockers to neutralise a specific stress hormone and prevent dangerous heart rhythms following a heart attack. However, a new study led by Associate Professor Neil Herring and published in the European Heart Journal has uncovered evidence for an additional stress hormone acting as a key trigger for dangerous heart rhythms that is not currently targeted by these drugs.

Upcoming events

Joint BHF Regenerative Medicine Centres Symposium June 2020

Tuesday, 16 June 2020, 9am to 6pm @ Imperial College, London

BHF CRM Annual Oxbridge Meeting, September 2020

Friday, 25 September 2020, 10am to 5pm @ The Royal Society, Carlton House Terrace, London